BioPharma Credit Pink Sheet Forecast - Polynomial Regression
| BOPCFDelisted Stock | USD 0.92 0.00 0.00% |
The Polynomial Regression forecasted value of BioPharma Credit PLC on the next trading day is expected to be 0.90 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.51. BioPharma Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of BioPharma Credit's historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of BioPharma Credit's pink sheet price is roughly 67 suggesting that the pink sheet is rather overbought by investors as of 7th of January 2026. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling BioPharma, making its price go up or down. Momentum 67
Buy Stretched
Oversold | Overbought |
Using BioPharma Credit hype-based prediction, you can estimate the value of BioPharma Credit PLC from the perspective of BioPharma Credit response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of BioPharma Credit PLC on the next trading day is expected to be 0.90 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.51. BioPharma Credit after-hype prediction price | USD 0.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BioPharma |
BioPharma Credit Additional Predictive Modules
Most predictive techniques to examine BioPharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioPharma using various technical indicators. When you analyze BioPharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BioPharma Credit Polynomial Regression Price Forecast For the 8th of January
Given 90 days horizon, the Polynomial Regression forecasted value of BioPharma Credit PLC on the next trading day is expected to be 0.90 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0001, and the sum of the absolute errors of 0.51.Please note that although there have been many attempts to predict BioPharma Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BioPharma Credit's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BioPharma Credit Pink Sheet Forecast Pattern
| Backtest BioPharma Credit | BioPharma Credit Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of BioPharma Credit pink sheet data series using in forecasting. Note that when a statistical model is used to represent BioPharma Credit pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.1323 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0083 |
| MAPE | Mean absolute percentage error | 0.0092 |
| SAE | Sum of the absolute errors | 0.5055 |
Predictive Modules for BioPharma Credit
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioPharma Credit PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioPharma Credit's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioPharma Credit Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioPharma Credit pink sheet to make a market-neutral strategy. Peer analysis of BioPharma Credit could also be used in its relative valuation, which is a method of valuing BioPharma Credit by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BioPharma Credit Market Strength Events
Market strength indicators help investors to evaluate how BioPharma Credit pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioPharma Credit shares will generate the highest return on investment. By undertsting and applying BioPharma Credit pink sheet market strength indicators, traders can identify BioPharma Credit PLC entry and exit signals to maximize returns.
BioPharma Credit Risk Indicators
The analysis of BioPharma Credit's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioPharma Credit's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biopharma pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.6709 | |||
| Standard Deviation | 1.51 | |||
| Variance | 2.27 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in BioPharma Pink Sheet
If you are still planning to invest in BioPharma Credit PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPharma Credit's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |